Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the future of pharmaceutical advertising, health ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

Rep. Diana DeGette is again searching for a Republican co-champion to help take a second swing at passing a second iteration ...

The US Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over.

With the help of “Zepbound,” a weight loss injectable with the same active ingredient as Mounjaro, tirzepatide, he lost about ...

New Alzheimer's disease drugs, a world-first skin cancer vaccine, and personalised health apps that change the way we track ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Around the holidays, when many people are baking cookies for Santa, enjoying cocktail parties or having festive family feasts ...